Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q1

6523.TEDINET S100RO21
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥81.3bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥356.4bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥81.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥1.7bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥2.0bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax−¥3.6bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥179m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥3.2bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥3.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥7.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥3.1bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income−¥7.0bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥572.5bnat 2023-06-30Cons.Assets IFRS
Total assets¥561.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥595.7bnat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥428.9bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥422.7bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥143.7bnat 2023-06-30Cons.Equity IFRS
Net assets / equity¥138.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥137.7bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥144.0bnat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥138.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥136.9bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥54.1bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥82.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥8.2bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥21.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥14.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥11.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-25.52023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-25.842022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-57.262022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-25.52023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-25.842022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-57.262022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio25.2%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.6%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio23.0%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥2.2bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
—segment totalrevenue2023-04-01 → 2023-06-30¥80.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥80.8bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.9bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥6.7bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.0bn
—segment totalrevenue2022-04-01 → 2022-06-30¥80.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥80.9bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥8.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 864
ItemContextValueUnit
Assets IFRSCurrentQuarterInstant572547000000JPY
Trade and other payables cl IFRSPrior1YearInstant65639000000JPY
Trade and other payables cl IFRSCurrentQuarterInstant63765000000JPY
Borrowings cl IFRSPrior1YearInstant30212000000JPY
Borrowings cl IFRSCurrentQuarterInstant29371000000JPY
Income taxes payable cl IFRSPrior1YearInstant2393000000JPY
Income taxes payable cl IFRSCurrentQuarterInstant2511000000JPY
Provisions cl IFRSPrior1YearInstant4715000000JPY
Provisions cl IFRSCurrentQuarterInstant6367000000JPY
Other financial liabilities cl IFRSPrior1YearInstant5554000000JPY
Other financial liabilities cl IFRSCurrentQuarterInstant5934000000JPY
Other current liabilities cl IFRSPrior1YearInstant21325000000JPY
Other current liabilities cl IFRSCurrentQuarterInstant23581000000JPY
Total current liabilities IFRSPrior1YearInstant129842000000JPY
Total current liabilities IFRSCurrentQuarterInstant131530000000JPY
Trade and other payables ncl IFRSPrior1YearInstant1230000000JPY
Trade and other payables ncl IFRSCurrentQuarterInstant1121000000JPY
Borrowings ncl IFRSPrior1YearInstant262403000000JPY
Borrowings ncl IFRSCurrentQuarterInstant265898000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant7875000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant8373000000JPY
Provisions ncl IFRSPrior1YearInstant3180000000JPY
Provisions ncl IFRSCurrentQuarterInstant3183000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant9225000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant9054000000JPY
Deferred tax liabilities IFRSPrior1YearInstant7312000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant8237000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant1670000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant1457000000JPY
Non current labilities IFRSPrior1YearInstant292898000000JPY
Non current labilities IFRSCurrentQuarterInstant297325000000JPY
Liabilities IFRSPrior1YearInstant422740000000JPY
Liabilities IFRSCurrentQuarterInstant428856000000JPY
Share capital IFRSPrior1YearInstant47946000000JPY
Share capital IFRSCurrentQuarterInstant48164000000JPY
Capital surplus IFRSPrior1YearInstant43641000000JPY
Capital surplus IFRSCurrentQuarterInstant41997000000JPY
Retained earnings IFRSPrior1YearInstant17081000000JPY
Retained earnings IFRSCurrentQuarterInstant9709000000JPY
Treasury shares IFRSPrior1YearInstant-568000000JPY
Treasury shares IFRSCurrentQuarterInstant-568000000JPY
Other components of equity IFRSPrior1YearInstant29906000000JPY
Other components of equity IFRSCurrentQuarterInstant44708000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant138008000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant144010000000JPY
Non controlling interests IFRSPrior1YearInstant819000000JPY
Non controlling interests IFRSCurrentQuarterInstant-320000000JPY
Equity IFRSPrior1YearInstant138827000000JPY
Equity IFRSCurrentQuarterInstant143690000000JPY
Liabilities and equity IFRSPrior1YearInstant561567000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass